Zim Laboratories share news and announcements
NSE: ZIMLABBSE: 541400Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹132.12.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹677 Cr1,933rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 183.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 2.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 1.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.42
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,16,71445.7% delivered
Zim Laboratories share news and announcements
235 announcements, routine notices left out, newest first. Page 2 of 5.
Feb 2026
2 Feb · Management
Jan 2026
21 Jan · Board meeting
15 Jan · Board meeting
Dec 2025
13 Dec · Analysts
8 Dec · Analysts
Nov 2025
14 Nov · Meeting
12 Nov · Board meeting
10 Nov · Analysts
Oct 2025
13 Oct · Meeting
Sep 2025
19 Sep · Disclosure
19 Sep · Management
Aug 2025
7 Aug · Analysts
7 Aug · Management
7 Aug · Business
7 Aug · Board meeting
6 Aug · Analysts
1 Aug · General Updates
Jul 2025
21 Jul · Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
11 Jul · Business
Jun 2025
19 Jun · Business
17 Jun · Analysts
5 Jun · General Updates
3 Jun · General Updates
May 2025
29 May · Analysts
20 May · Management
20 May · Results
14 May · Analysts
8 May · General Updates
Apr 2025
28 Apr · Management